Using Data from the Canadian Post-marketing Spontaneous Pharmacovigilance System for Drug Safety Research: A Feasibility Study.

Samuel AkinolaCarolina Galli da SilveiraSonia CorbinMaude LavalléeMagalie ThibaultJennifer GonellaFernanda Raphael Escobar GimenesJacinthe Leclerc

Published in: Pharmaceutical medicine (2021)

It seems feasible to use data from the Canadian Post-marketing Spontaneous Pharmacovigilance System for academic drug safety research. Upcoming studies should validate the quality of reports compared to actual medical charts.

Keyphrases

adverse drug
electronic health record
drug induced
big data
healthcare
emergency department
data analysis